Ligand Pharmaceuticals Inc. (Nasdaq:LGND) announced that it has entered into a global licensing agreement with Chiva Pharmaceuticals, Inc. for Fablyn (lasofoxifene), a selective estrogen receptor modulator (SERM) that was approved in the EU in 2009 for the treatment of osteoporosis in post-menopausal women at increased risk of fracture.
Ligand Pharmaceuticals Incorporated operates as a biotechnology company. It principally engages in the development and acquisition of royalty revenue generating assets.
MAJESTIC GOLD CORP (MJGCF.PK)
MAJESTIC GOLD CORP (MJGCF.PK) engages in the exploration and development of mineral properties in China. The company focuses on its gold project located in the prolific gold region of Song Jiagou in eastern Shandong Province. Majestic Gold Corp. is headquartered in Vancouver, Canada.
Gold had fascinated our ancestors long ago. Primarily, it was easy to find it from a geological viewpoint; they soon discovered it was also very easy to work and resistant to corrosion. Gold's natural beauty as well as its unique intrinsic structure turned it into the widest known metal. It was also linked to a variety of symbolism and ideologies. Gold is widely used in industry, due to its exclusive chemical structure and properties. Gold is the most malleable and ductile of metals. Gold can be drawn into very thin wire and, therefore, used in electricity, in several high-energy applications as well as in electrical contacts.
( Read the full article and the disclaimer at http://crweselect.com/26788/stock-alerts/lgnd-mjgcf-spbc-gblhf-qlgc-stoc...)